NO321481B1 - Fremgangsmate ekstraksjon av lipider fra marint og akvatisk dyrevev - Google Patents
Fremgangsmate ekstraksjon av lipider fra marint og akvatisk dyrevev Download PDFInfo
- Publication number
- NO321481B1 NO321481B1 NO20011915A NO20011915A NO321481B1 NO 321481 B1 NO321481 B1 NO 321481B1 NO 20011915 A NO20011915 A NO 20011915A NO 20011915 A NO20011915 A NO 20011915A NO 321481 B1 NO321481 B1 NO 321481B1
- Authority
- NO
- Norway
- Prior art keywords
- marine
- extraction
- lipid
- animal material
- solvent
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title claims abstract description 85
- 238000000034 method Methods 0.000 title claims abstract description 85
- 238000000605 extraction Methods 0.000 title claims abstract description 59
- 241001465754 Metazoa Species 0.000 title claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 51
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 42
- 241000239366 Euphausiacea Species 0.000 claims abstract description 38
- 239000000463 material Substances 0.000 claims abstract description 25
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims abstract description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 150000002148 esters Chemical class 0.000 claims abstract description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 105
- 239000002904 solvent Substances 0.000 claims description 34
- 241000251468 Actinopterygii Species 0.000 claims description 19
- 239000007787 solid Substances 0.000 claims description 16
- 238000001704 evaporation Methods 0.000 claims description 15
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 230000008020 evaporation Effects 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 9
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 7
- 235000012682 canthaxanthin Nutrition 0.000 claims description 7
- 239000001659 canthaxanthin Substances 0.000 claims description 7
- 229940008033 canthaxanthin Drugs 0.000 claims description 7
- 235000021466 carotenoid Nutrition 0.000 claims description 6
- 150000001747 carotenoids Chemical class 0.000 claims description 6
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 5
- 235000013793 astaxanthin Nutrition 0.000 claims description 5
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 5
- 239000001168 astaxanthin Substances 0.000 claims description 5
- 229940022405 astaxanthin Drugs 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 239000002537 cosmetic Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 3
- 231100000331 toxic Toxicity 0.000 claims description 3
- 230000002588 toxic effect Effects 0.000 claims description 3
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
- 244000144974 aquaculture Species 0.000 claims description 2
- 238000009360 aquaculture Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 208000017169 kidney disease Diseases 0.000 claims description 2
- 206010025135 lupus erythematosus Diseases 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 238000007738 vacuum evaporation Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 238000003811 acetone extraction Methods 0.000 abstract description 5
- 238000000638 solvent extraction Methods 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- 239000003921 oil Substances 0.000 description 18
- 235000019688 fish Nutrition 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 15
- 239000000194 fatty acid Substances 0.000 description 15
- 229930195729 fatty acid Natural products 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 15
- 241001472118 Euphausia pacifica Species 0.000 description 13
- 238000004809 thin layer chromatography Methods 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000007935 neutral effect Effects 0.000 description 8
- 150000003904 phospholipids Chemical class 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 239000010775 animal oil Substances 0.000 description 7
- 238000001030 gas--liquid chromatography Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241001290266 Sciaenops ocellatus Species 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000212925 Meganyctiphanes norvegica Species 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 241000239263 Calanus Species 0.000 description 3
- 241000251730 Chondrichthyes Species 0.000 description 3
- 229940107161 cholesterol Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000002797 proteolythic effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 238000009010 Bradford assay Methods 0.000 description 2
- 241000283153 Cetacea Species 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241001669573 Galeorhinus galeus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000170625 Mustelus schmitti Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000277331 Salmonidae Species 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 241000063156 Squatina squatina Species 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- 235000006486 human diet Nutrition 0.000 description 2
- 229940106134 krill oil Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000016444 Benign adult familial myoclonic epilepsy Diseases 0.000 description 1
- 241000123826 Lutjanus campechanus Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241001486234 Sciota Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 241000680651 Thysanoessa raschii Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- -1 acetone Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 229940100609 all-trans-retinol Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 208000016427 familial adult myoclonic epilepsy Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Fats And Perfumes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Fodder In General (AREA)
- Farming Of Fish And Shellfish (AREA)
- Edible Oils And Fats (AREA)
- Feed For Specific Animals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Meat, Egg Or Seafood Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002251265A CA2251265A1 (fr) | 1998-10-21 | 1998-10-21 | Procede d'extraction des lipides de tissus d'animaux aquatiques produisant un residu deshydrate |
| PCT/CA1999/000987 WO2000023546A1 (fr) | 1998-10-21 | 1999-10-21 | Procede d'extraction de lipides des tissus d'animaux marins et aquatiques |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20011915D0 NO20011915D0 (no) | 2001-04-18 |
| NO20011915L NO20011915L (no) | 2001-06-21 |
| NO321481B1 true NO321481B1 (no) | 2006-05-15 |
Family
ID=4162941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011915A NO321481B1 (no) | 1998-10-21 | 2001-04-18 | Fremgangsmate ekstraksjon av lipider fra marint og akvatisk dyrevev |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6800299B1 (fr) |
| EP (1) | EP1123368B1 (fr) |
| JP (2) | JP4181305B2 (fr) |
| KR (1) | KR100454899B1 (fr) |
| CN (1) | CN1269940C (fr) |
| AT (1) | ATE391763T1 (fr) |
| AU (1) | AU765464B2 (fr) |
| BR (1) | BR9914699B1 (fr) |
| CA (1) | CA2251265A1 (fr) |
| DE (1) | DE69938504T2 (fr) |
| DK (1) | DK1123368T3 (fr) |
| ES (1) | ES2306527T3 (fr) |
| HK (1) | HK1038765A1 (fr) |
| NO (1) | NO321481B1 (fr) |
| PL (1) | PL201771B1 (fr) |
| PT (1) | PT1123368E (fr) |
| RU (1) | RU2236441C2 (fr) |
| UA (1) | UA75029C2 (fr) |
| WO (1) | WO2000023546A1 (fr) |
| ZA (1) | ZA200103235B (fr) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2251265A1 (fr) * | 1998-10-21 | 2000-04-21 | Universite De Sherbrooke | Procede d'extraction des lipides de tissus d'animaux aquatiques produisant un residu deshydrate |
| AUPQ480399A0 (en) * | 1999-12-22 | 2000-02-03 | Commonwealth Scientific And Industrial Research Organisation | Unsaturated fatty acids and their uses in therapy |
| ES2386841T3 (es) * | 2001-06-18 | 2012-09-03 | Neptune Technologies & Bioressources Inc. | Extractos de krill para la prevención y/o el tratamiento de enfermedades cardiovasculares |
| AU2013205516B2 (en) * | 2001-07-27 | 2014-04-24 | Aker Biomarine Antarctic As | Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| US8030348B2 (en) | 2001-07-27 | 2011-10-04 | Neptune Technologies & Bioressources, Inc. | Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| US8052992B2 (en) | 2003-10-22 | 2011-11-08 | Enzymotec Ltd. | Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions |
| US20050130937A1 (en) | 2003-10-22 | 2005-06-16 | Enzymotec Ltd. | Lipids containing omega-3 and omega-6 fatty acids |
| US7935365B2 (en) | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
| DE602005010826D1 (de) * | 2004-01-30 | 2008-12-18 | Bionovate Ltd | Lösungsmittelextraktion von lipiden aus perna canaliculus |
| CA2555281C (fr) * | 2004-02-06 | 2012-11-13 | Adrien Beaudoin | Methode pour prevenir l'oxydation de lipides dans des huiles animales ou vegetales et compositions utilisees pour cette methode |
| US7666447B2 (en) * | 2004-10-08 | 2010-02-23 | Pharmanutrients | Compositions including Krill extracts and conjugated linoleic acid and methods of using same |
| US8404875B2 (en) | 2005-02-07 | 2013-03-26 | Adrien Beaudoin | Method for preventing the oxidation of lipids in animal and vegetable oils and compositions produced by the method thereof |
| GB0506788D0 (en) * | 2005-04-04 | 2005-05-11 | Biosea Man As | Process |
| AR059659A1 (es) * | 2006-01-13 | 2008-04-23 | Alfa Copenhagen S S | Metodo para la extraccion |
| WO2008050219A2 (fr) * | 2006-10-24 | 2008-05-02 | Krill A/S | Procédé et appareil pour une extraction améliorée de fractions liquides à partir d'animaux marins et aquatiques |
| KR20090085682A (ko) * | 2006-11-16 | 2009-08-07 | 프로노바 바이오파마 노르지 에이에스 | 크릴로부터 오메가-3가 풍부한 해양 인지질을 제조하는 방법 |
| JP2008239500A (ja) * | 2007-03-25 | 2008-10-09 | Nippon Suisan Kaisha Ltd | レプチン分泌促進剤 |
| AU2011213836B2 (en) * | 2007-03-28 | 2013-11-14 | Aker Biomarine Antarctic As | Bioeffective krill oil compositions |
| WO2008117062A1 (fr) | 2007-03-28 | 2008-10-02 | Aker Biomarine Asa | Compositions d'huile de krill biologiquement efficaces |
| AU2014100736B4 (en) * | 2007-03-28 | 2014-09-18 | Aker Biomarine Antarctic As | Processes and products thereof |
| US8697138B2 (en) | 2007-03-28 | 2014-04-15 | Aker Biomarine As | Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
| US20080254135A1 (en) * | 2007-04-10 | 2008-10-16 | Marvin Heuer | Resveratrol-containing compositions for general health and vitality |
| US20100226977A1 (en) * | 2007-08-29 | 2010-09-09 | Aker Biomarine Asa | Low viscosity phospholipid compositions |
| NZ598062A (en) * | 2007-08-29 | 2013-11-29 | Aker Biomarine As | A new method for making krill meal |
| AU2014100741B4 (en) * | 2007-08-29 | 2014-09-11 | Aker Biomarine Antarctic As | Processes and products thereof |
| EP2110027A1 (fr) * | 2008-04-01 | 2009-10-21 | Nestec S.A. | Acides gras poly-insaturés à chaîne longue (LC-PUFA)dans la nutrition maternelle pendant la grossesse et l'allaitement |
| BRPI0912749A2 (pt) * | 2008-05-15 | 2017-05-23 | Pronova Biopharma Norge As | processo de óleo de krill. |
| EP2334199B1 (fr) | 2008-09-12 | 2017-06-28 | Rimfrost Technologies AS | Procédé de réduction de la teneur en fluor lors de la production de concentrés protéinés à partir de krill |
| US8557297B2 (en) | 2008-09-12 | 2013-10-15 | Olympic Seafood, As | Method for processing crustaceans and products thereof |
| US9814256B2 (en) | 2009-09-14 | 2017-11-14 | Rimfrost Technologies As | Method for processing crustaceans to produce low fluoride/low trimethyl amine products thereof |
| US20100077654A1 (en) * | 2008-09-23 | 2010-04-01 | LiveFuels, Inc. | Systems and methods for producing biofuels from algae |
| JP5703021B2 (ja) * | 2008-09-26 | 2015-04-15 | 日本水産株式会社 | 脂質の濃縮方法 |
| WO2010038964A2 (fr) * | 2008-09-30 | 2010-04-08 | 주식회사 유맥스 | Procédé d'extraction et de séparation de matières actives de krill, et produits associés |
| KR101024491B1 (ko) * | 2008-12-31 | 2011-03-31 | 인성실업(주) | 해양 동물로부터 지질을 추출하는 방법 |
| CA2750153C (fr) | 2009-01-05 | 2016-11-08 | Calanus As | Composition d'huile biologique, formulations comprenant la composition d'huile, et utilisation de celle-ci pour prevenir ou traiter une maladie cardiovasculaire |
| AU2010214924B2 (en) | 2009-02-18 | 2015-10-22 | Walsh Intellectual Property Ltd. | A tubular duct member |
| US8372812B2 (en) | 2009-02-26 | 2013-02-12 | Aker Biomarine Asa | Phospholipid and protein tablets |
| WO2010121094A1 (fr) | 2009-04-17 | 2010-10-21 | Livefuels. Inc. | Systèmes et procédés pour cultiver des algues avec des bivalves |
| EP2435055A2 (fr) | 2009-05-28 | 2012-04-04 | Aker Biomarine ASA | Procédés d'utilisation de l'huile de krill à des fins de traitement des facteurs de risque associés aux affections métaboliques et obésité |
| US20120136053A1 (en) * | 2009-06-12 | 2012-05-31 | Calanus As | Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders |
| US20120137574A1 (en) * | 2009-06-16 | 2012-06-07 | LiveFuels, Inc. | Systems and methods for harvesting algae |
| US9216164B2 (en) | 2009-07-23 | 2015-12-22 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
| US9399047B2 (en) | 2009-07-23 | 2016-07-26 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using phospholipids and roe extract |
| US9402857B2 (en) | 2009-07-23 | 2016-08-02 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin |
| US8557275B2 (en) | 2009-07-23 | 2013-10-15 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
| US9913810B2 (en) | 2009-07-23 | 2018-03-13 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using phospholipids and astaxanthin |
| US9238043B2 (en) | 2009-07-23 | 2016-01-19 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using algae based oils |
| US8481072B2 (en) | 2009-07-23 | 2013-07-09 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain |
| UY32989A (es) | 2009-10-29 | 2011-04-29 | Acasti Pharma Inc | Coposiciones terapéuticas concentradas de fosfolípidos |
| EP2493328A1 (fr) | 2009-10-30 | 2012-09-05 | Tharos Ltd. | Procédé sans solvant pour l'obtention d'huile de krill enrichie en phospholipides et d'huile de krill enrichie en lipides neutres |
| MX2012005460A (es) * | 2009-11-11 | 2012-07-20 | Dynasep Inc | Metodo de secado con acetona eficiente en energia. |
| KR101204391B1 (ko) * | 2010-03-10 | 2012-11-26 | 인성실업(주) | 지질추출장치，이 장치를 가지는 어분제조기 |
| CN103096904B (zh) * | 2010-09-01 | 2016-03-09 | 日本水产株式会社 | 酒精性伤害缓解剂 |
| CN102071101B (zh) * | 2011-01-21 | 2012-10-10 | 山东科芮尔生物制品有限公司 | 一种从南极磷虾中提取富含磷脂的磷虾油的方法 |
| US20120231087A1 (en) | 2011-03-07 | 2012-09-13 | Olympic Seafood | Compositions And Methods for Nutritional Supplementation |
| US9487716B2 (en) | 2011-05-06 | 2016-11-08 | LiveFuels, Inc. | Sourcing phosphorus and other nutrients from the ocean via ocean thermal energy conversion systems |
| US20120284165A1 (en) * | 2011-05-06 | 2012-11-08 | LiveFuels, Inc. | Method for removing carbon dioxide from ocean water and quantifying the carbon dioxide so removed |
| CN102224855B (zh) * | 2011-05-13 | 2013-05-08 | 中国海洋大学 | 一种南极磷虾中脂质的富集方法 |
| US8846604B2 (en) | 2011-09-02 | 2014-09-30 | Artic Nutrition AS | Lipid compositions with high DHA content |
| WO2013149384A1 (fr) * | 2012-04-05 | 2013-10-10 | Nippon Suisan Kaisha, Ltd. | Agent de prévention d'atrophie cérébrale |
| RU2506314C2 (ru) * | 2012-05-04 | 2014-02-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) | Способ качественного и количественного анализа липидов, прочносвязанных с геномной днк |
| CN102731360B (zh) * | 2012-07-18 | 2015-03-25 | 山东师范大学 | 一种从南极磷虾中提取虾青素的方法 |
| CN102732382B (zh) * | 2012-07-18 | 2013-07-03 | 山东师范大学 | 一种从南极磷虾中提取蜡的方法 |
| EP3756658A1 (fr) * | 2012-09-24 | 2020-12-30 | Aker Biomarine Antarctic As | Compositions d'oméga-3 |
| US20150252285A1 (en) * | 2012-09-25 | 2015-09-10 | The Johns Hopkins University | Methods for extraction of lipids from wet algal biomass |
| WO2014184655A1 (fr) | 2013-02-07 | 2014-11-20 | Olympic Seafood As | Procédés d'utilisation de complexes phospholipide-peptide-protéine de crustacés |
| AU2014203179C1 (en) | 2013-06-14 | 2017-05-04 | Aker Biomarine Antarctic As | Lipid extraction processes |
| US9399749B2 (en) | 2013-08-13 | 2016-07-26 | Darling Ingredients Inc. | Lipid extraction |
| CN103773596B (zh) * | 2013-12-31 | 2016-05-18 | 上海复力生物医药科技有限公司 | 磷虾油的制备方法 |
| GB201400431D0 (en) | 2014-01-10 | 2014-02-26 | Aker Biomarine As | Phospholipid compositions and their preparation |
| US20180207204A1 (en) | 2014-02-11 | 2018-07-26 | Enzymotec Ltd. | Krill oil preparations with optimal mineral and metal composition, low impurities and low and stable tma levels |
| CN103864841A (zh) * | 2014-03-12 | 2014-06-18 | 威海博宇食品有限公司 | 一种从水产动物卵中提取与精制磷脂的方法 |
| CN106535650A (zh) | 2014-04-30 | 2017-03-22 | 恩兹莫特克有限公司 | 磷虾油制剂和它们的用途 |
| US9701923B2 (en) | 2014-10-24 | 2017-07-11 | Darling Ingredients Inc. | Lipid extraction |
| AU2016217559A1 (en) | 2015-02-11 | 2017-08-31 | Aker Biomarine Antarctic As | Lipid extraction processes |
| NZ747847A (en) | 2015-02-11 | 2023-06-30 | Aker Biomarine Antarctic As | Lipid compositions |
| CN105152910B (zh) * | 2015-07-23 | 2017-06-30 | 山东师范大学 | 一种从脱脂南极磷虾中提取及检测棕榈酸的方法 |
| WO2018037420A1 (fr) * | 2016-08-24 | 2018-03-01 | Samuel Philip | Procédé amélioré de traitement et d'extraction d'huile |
| WO2018183815A1 (fr) * | 2017-03-31 | 2018-10-04 | Avoca Llc | Procédés de préparation de compositions de krill enrichies en phospholipides |
| JP7246057B2 (ja) | 2017-11-17 | 2023-03-27 | 株式会社新富士空調 | 角ダクト用ボタンパンチはぜ構造および角ダクト |
| KR20200096593A (ko) | 2017-12-04 | 2020-08-12 | 림프로스트 테크놀로지스 에이에스 | 갑각류 어획물로부터 단백질 인지질 복합체를 제조하는 방법 |
| CN108130193B (zh) * | 2017-12-21 | 2021-04-02 | 山东师范大学 | 一种提高南极磷虾油脂提取率的方法 |
| UA126417C2 (uk) | 2017-12-22 | 2022-09-28 | Фармалінк Інтернешнл Лімітед | Комбінації ліпідів |
| CN109053420B (zh) * | 2018-08-21 | 2021-03-16 | 浙江海洋大学 | 一种从桡足类中提取dha和epa的方法 |
| KR102676437B1 (ko) | 2019-03-15 | 2024-06-19 | 야마하하쓰도키 가부시키가이샤 | 기정 루트 주행 차량 |
| CN110361497B (zh) * | 2019-08-02 | 2021-06-25 | 山东师范大学 | 一种南极磷虾中氨基酸的检测方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT331374B (de) | 1972-12-22 | 1976-08-25 | Studiengesellschaft Kohle Mbh | Verfahren zur gewinnung von fetten und olen aus pflanzlichen und tierischen produkten |
| JPS5248191B2 (fr) * | 1974-12-27 | 1977-12-08 | ||
| JPS53112195A (en) * | 1977-03-10 | 1978-09-30 | Nippon Paint Co Ltd | Method for producing food for fish |
| CA1098900A (fr) | 1977-12-14 | 1981-04-07 | Sergei V. Rogozhin | Methode de traitement du krill pour la production de proteines, de lipides et de chitine |
| NO147365C (no) * | 1980-11-27 | 1983-03-30 | Jan Raa | Fremgangsmaate til fremstilling av astaxanthin i en form som er egnet for innlemmelse i for for oppdrettfisk. |
| AU573730B2 (en) * | 1982-10-25 | 1988-06-23 | Antarctic Pharma Ab | Enzyme composition from euphausiaceae (antarctic krill) as cleaning agent |
| JPS59196032A (ja) * | 1983-04-23 | 1984-11-07 | Fumio Nishikawa | オキアミの変性防止及び鮮度保持の方法 |
| JPS6035057A (ja) * | 1984-06-27 | 1985-02-22 | San Ei Chem Ind Ltd | 黄橙色ないし赤橙色色素の製法 |
| US5006281A (en) | 1985-03-26 | 1991-04-09 | Century Laboratories, Inc. | Process for the production of a marine animal oil |
| JPS6390598A (ja) * | 1986-10-03 | 1988-04-21 | 日本油脂株式会社 | ドコサヘキサエン酸を含む脂質の製造法 |
| JPS63162793A (ja) * | 1986-12-26 | 1988-07-06 | 焼津水産化学工業株式会社 | 脂質の抽出方法 |
| JP2963152B2 (ja) | 1990-06-28 | 1999-10-12 | クロリンエンジニアズ株式会社 | オキアミからの色素の抽出分離方法 |
| DE4219360C2 (de) | 1992-06-12 | 1994-07-28 | Milupa Ag | Verfahren zur Gewinnung von Lipiden mit einem hohen Anteil von langkettig-hochungesättigten Fettsäuren |
| JPH07107920A (ja) * | 1993-10-12 | 1995-04-25 | Nichiwa Sangyo Kk | 鶏用飼料 |
| JPH08198754A (ja) | 1995-01-23 | 1996-08-06 | Yakult Honsha Co Ltd | 脳機能改善剤 |
| JP3398248B2 (ja) | 1995-03-16 | 2003-04-21 | 新日本石油株式会社 | キサントフィル化合物の精製方法 |
| JPH09143063A (ja) * | 1995-11-22 | 1997-06-03 | Kose Corp | 外用に適する組成物 |
| JPH09308459A (ja) * | 1996-05-20 | 1997-12-02 | Nof Corp | 高度不飽和脂肪酸含有栄養組成物 |
| US6055936A (en) * | 1997-01-21 | 2000-05-02 | Collin; Peter Donald | Sea cucumber carotenoid lipid fractions and process |
| CA2251265A1 (fr) * | 1998-10-21 | 2000-04-21 | Universite De Sherbrooke | Procede d'extraction des lipides de tissus d'animaux aquatiques produisant un residu deshydrate |
-
1998
- 1998-10-21 CA CA002251265A patent/CA2251265A1/fr not_active Abandoned
-
1999
- 1999-10-21 DE DE1999638504 patent/DE69938504T2/de not_active Expired - Lifetime
- 1999-10-21 ES ES99952180T patent/ES2306527T3/es not_active Expired - Lifetime
- 1999-10-21 EP EP99952180A patent/EP1123368B1/fr not_active Expired - Lifetime
- 1999-10-21 PL PL347396A patent/PL201771B1/pl unknown
- 1999-10-21 JP JP2000577261A patent/JP4181305B2/ja not_active Expired - Fee Related
- 1999-10-21 WO PCT/CA1999/000987 patent/WO2000023546A1/fr active Search and Examination
- 1999-10-21 KR KR10-2001-7004998A patent/KR100454899B1/ko not_active IP Right Cessation
- 1999-10-21 DK DK99952180T patent/DK1123368T3/da active
- 1999-10-21 UA UA2001042679A patent/UA75029C2/uk unknown
- 1999-10-21 AU AU64552/99A patent/AU765464B2/en not_active Ceased
- 1999-10-21 US US09/830,146 patent/US6800299B1/en not_active Expired - Lifetime
- 1999-10-21 CN CNB998124176A patent/CN1269940C/zh not_active Expired - Fee Related
- 1999-10-21 BR BRPI9914699-1A patent/BR9914699B1/pt not_active IP Right Cessation
- 1999-10-21 AT AT99952180T patent/ATE391763T1/de active
- 1999-10-21 RU RU2001113503A patent/RU2236441C2/ru not_active IP Right Cessation
- 1999-10-21 PT PT99952180T patent/PT1123368E/pt unknown
-
2001
- 2001-04-18 NO NO20011915A patent/NO321481B1/no not_active IP Right Cessation
- 2001-04-20 ZA ZA200103235A patent/ZA200103235B/en unknown
-
2002
- 2002-01-15 HK HK02100272A patent/HK1038765A1/xx not_active IP Right Cessation
-
2007
- 2007-11-02 JP JP2007285980A patent/JP5172281B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002527604A (ja) | 2002-08-27 |
| BR9914699A (pt) | 2001-07-10 |
| HK1038765A1 (en) | 2002-03-28 |
| ES2306527T3 (es) | 2008-11-01 |
| CN1324394A (zh) | 2001-11-28 |
| PL201771B1 (pl) | 2009-05-29 |
| DK1123368T3 (da) | 2008-08-04 |
| EP1123368B1 (fr) | 2008-04-09 |
| ATE391763T1 (de) | 2008-04-15 |
| PL347396A1 (en) | 2002-04-08 |
| DE69938504D1 (de) | 2008-05-21 |
| US6800299B1 (en) | 2004-10-05 |
| CN1269940C (zh) | 2006-08-16 |
| RU2236441C2 (ru) | 2004-09-20 |
| KR20010103615A (ko) | 2001-11-23 |
| WO2000023546A1 (fr) | 2000-04-27 |
| DE69938504T2 (de) | 2009-06-10 |
| PT1123368E (pt) | 2008-07-18 |
| CA2251265A1 (fr) | 2000-04-21 |
| NO20011915L (no) | 2001-06-21 |
| JP5172281B2 (ja) | 2013-03-27 |
| EP1123368A1 (fr) | 2001-08-16 |
| ZA200103235B (en) | 2002-06-20 |
| UA75029C2 (en) | 2006-03-15 |
| NO20011915D0 (no) | 2001-04-18 |
| AU6455299A (en) | 2000-05-08 |
| AU765464B2 (en) | 2003-09-18 |
| KR100454899B1 (ko) | 2004-11-06 |
| JP4181305B2 (ja) | 2008-11-12 |
| BR9914699B1 (pt) | 2009-12-01 |
| JP2008150586A (ja) | 2008-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO321481B1 (no) | Fremgangsmate ekstraksjon av lipider fra marint og akvatisk dyrevev | |
| AU2012364278B2 (en) | Method for processing crustaceans to produce low fluoride/low trimethyl amine products thereof | |
| KR100816896B1 (ko) | 해양 포유동물 조직으로부터 단백질을 추출하는 방법 | |
| US20150030751A1 (en) | Method for Processing Crustaceans to Produce Low Fluoride/Low Trimethyl Amine Products Thereof | |
| US20080268117A1 (en) | Method of purifying oils containing epa and dha | |
| CA2346979C (fr) | Procede d'extraction de lipides des tissus d'animaux marins et aquatiques | |
| MXPA01003955A (en) | Method of extracting lipids from marine and aquatic animal tissues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |